4.5 Article Proceedings Paper

Cellular immunity and immunopathology in autoimmune Addison's disease

Journal

MOLECULAR AND CELLULAR ENDOCRINOLOGY
Volume 336, Issue 1-2, Pages 180-190

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.mce.2010.12.015

Keywords

21-Hydroxylase; Addison's disease; Adrenal cortex; Adrenalitis; Autoimmunity

Ask authors/readers for more resources

Autoimmune adrenocortical failure, or Addison's disease, is a prototypical organ-specific autoimmune disorder. In common with related autoimmune endocrinopathies. Addison's disease is only manageable to a certain extent with replacement therapy being the only treatment option. Unfortunately, the available therapy does not restore the physiological hormone levels and biorhythm. The key to progress in treating and preventing autoimmune Addison's disease lies in improving our understanding of the predisposing factors, the mechanisms responsible for the progression of the disease, and the interactions between adrenal antigens and effector cells and molecules of the immune system. The aim of the present review is to summarize the current knowledge on the role of T cells and cellular immunity in the pathogenesis of autoimmune Addison's disease. (C) 2010 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available